(3R,4R,5S)-4-Acetylamino-5-amino-3-benzyloxy-cyclohex-1-enecarboxylic acid

ID: ALA310217

Chembl Id: CHEMBL310217

PubChem CID: 493865

Max Phase: Preclinical

Molecular Formula: C16H20N2O4

Molecular Weight: 304.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)N[C@@H]1[C@@H](N)CC(C(=O)O)=C[C@H]1OCc1ccccc1

Standard InChI:  InChI=1S/C16H20N2O4/c1-10(19)18-15-13(17)7-12(16(20)21)8-14(15)22-9-11-5-3-2-4-6-11/h2-6,8,13-15H,7,9,17H2,1H3,(H,18,19)(H,20,21)/t13-,14+,15+/m0/s1

Standard InChI Key:  FBEKRJIKDMARPJ-RRFJBIMHSA-N

Associated Targets(non-human)

NA Neuraminidase (1107 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NA Neuraminidase (392 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
nanH Sialidase (337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 304.35Molecular Weight (Monoisotopic): 304.1423AlogP: 0.82#Rotatable Bonds: 5
Polar Surface Area: 101.65Molecular Species: ZWITTERIONHBA: 4HBD: 3
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.95CX Basic pKa: 9.33CX LogP: -1.93CX LogD: -1.93
Aromatic Rings: 1Heavy Atoms: 22QED Weighted: 0.75Np Likeness Score: 0.81

References

1. Kim CU, Lew W, Williams MA, Wu H, Zhang L, Chen X, Escarpe PA, Mendel DB, Laver WG, Stevens RC..  (1998)  Structure-activity relationship studies of novel carbocyclic influenza neuraminidase inhibitors.,  41  (14): [PMID:9651151] [10.1021/jm980162u]
2. Wang Z, Cheng LP, Zhang XH, Pang W, Li L, Zhao JL..  (2017)  Design, synthesis and biological evaluation of novel oseltamivir derivatives as potent neuraminidase inhibitors.,  27  (24): [PMID:29141777] [10.1016/j.bmcl.2017.11.003]

Source